1. Home
  2. MRDB
  3. MRDB News

Latest MariaDB plc (MRDB) News on July 26, 2024

Offer Update
MRDB

Business Wire

3 days ago

Offer Update

Offer Update
MRDB

Business Wire

15 days ago

Offer Update

Offer Update
MRDB

Business Wire

21 days ago

Offer Update

MRDB

Business Wire

a month ago

Offer Update

MariaDB Files Second Quarter Fiscal 2024 Financial Results
MRDB

Business Wire

2 months ago

MariaDB Files Second Quarter Fiscal 2024 Financial Results

Extension of Deadline in Accordance with Rule 2.6(c) of the Irish Takeover Rules
MRDB

Business Wire

3 months ago

Extension of Deadline in Accordance with Rule 2.6(c) of the Irish Takeover Rules

Progress Software Corp. Statement regarding a Possible Offer for MariaDB plc
MRDB

GlobeNewswire

3 months ago

Progress Software Corp. Statement regarding a Possible Offer for MariaDB plc

Extension of Deadline in Accordance with Rule 2.6(c) of the Irish Takeover Rules
MRDB

Business Wire

3 months ago

Extension of Deadline in Accordance with Rule 2.6(c) of the Irish Takeover Rules

Form 8.1 Opening Position Disclosure (MariaDB plc)
MRDB

Business Wire

4 months ago

Form 8.1 Opening Position Disclosure (MariaDB plc)

Extension of Deadline In Accordance with Rule 2.6(c) of the Irish Takeover Rules
MRDB

Business Wire

4 months ago

Extension of Deadline In Accordance with Rule 2.6(c) of the Irish Takeover Rules

Announcement Regarding Possible Offer
MRDB

Business Wire

4 months ago

Announcement Regarding Possible Offer

Progress Software Confirms Bid to Acquire MariaDB
MRDB

The Wall Street Journal

4 months ago

Progress Software Confirms Bid to Acquire MariaDB

Form 8.1 Opening Position Disclosure (MariaDB plc)
MRDB

Business Wire

5 months ago

Form 8.1 Opening Position Disclosure (MariaDB plc)

Announcement Regarding Possible Offer
MRDB

Business Wire

5 months ago

Announcement Regarding Possible Offer

MariaDB Files First Quarter Fiscal 2024 Financial Results
MRDB

Business Wire

5 months ago

MariaDB Files First Quarter Fiscal 2024 Financial Results

Dow Jones, S&P 500 Power To Highs Despite This; Five New Stocks In Buy Areas
MRDB

Investor's Business Daily

6 months ago

Dow Jones, S&P 500 Power To Highs Despite This; Five New Stocks In Buy Areas

EpicQuest Education Announces Current Enrollment Metrics
MRDB

PR Newswire

6 months ago

EpicQuest Education Announces Current Enrollment Metrics

MariaDB Finalizes Spinoff of Its Geospatial Business
MRDB

Business Wire

6 months ago

MariaDB Finalizes Spinoff of Its Geospatial Business

Mullen's Majority-Owned Bollinger Motors Receives Orders Valued at ~$6M
MRDB

NewMediaWire

6 months ago

Mullen's Majority-Owned Bollinger Motors Receives Orders Valued at ~$6M

Mullen Invoices and Delivers 130 Additional Class 1 EV Cargo Vans to Randy Marion Automotive Group for $4,372,550.00
MRDB

GlobeNewswire

6 months ago

Mullen Invoices and Delivers 130 Additional Class 1 EV Cargo Vans to Randy Marion Automotive Group for $4,372,550.00

Mullen Automotive Sporty Five RS Featured in CarScoops Article
MRDB

NewMediaWire

6 months ago

Mullen Automotive Sporty Five RS Featured in CarScoops Article

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
MRDB

PR Newswire

6 months ago

Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
MRDB

GlobeNewswire

6 months ago

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

Quantum Computing Inc. Congratulates Achievement as its Engineers Receive Prestigious Edison Patent Award for Groundbreaking Quantum Cybersecurity Invention
MRDB

PR Newswire

6 months ago

Quantum Computing Inc. Congratulates Achievement as its Engineers Receive Prestigious Edison Patent Award for Groundbreaking Quantum Cybersecurity Invention

LED Lighting, EV Charging and Electrical Maintenance Provider Orion Announces Preliminary Q3’24 Revenue Growing to $25.8M-$26.2M and Improved Cash Position; Updates FY 2024 Anticipated Revenue Outlook to $90M-$95M
MRDB

GlobeNewswire

6 months ago

LED Lighting, EV Charging and Electrical Maintenance Provider Orion Announces Preliminary Q3’24 Revenue Growing to $25.8M-$26.2M and Improved Cash Position; Updates FY 2024 Anticipated Revenue Outlook to $90M-$95M

MRDB

GlobeNewswire

6 months ago

Huize Achieved a 98.6% Customer Satisfaction Rate for Online Customer Services and Helped over 1 Million Families Resolve Claims in 2023

Conifer Holdings Names New Board Chair; Appoints New Director
MRDB

GlobeNewswire

6 months ago

Conifer Holdings Names New Board Chair; Appoints New Director

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium
MRDB

PR Newswire

6 months ago

Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium

Here's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situation
MRDB

Simply Wall St.

6 months ago

Here's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situation

Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada
MRDB

GlobeNewswire

6 months ago

Eyenovia Re-Acquires Development and Commercialization Rights to MicroPine in the U.S. and Canada

Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data
MRDB

GlobeNewswire

6 months ago

Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results
MRDB

GlobeNewswire

6 months ago

Cellectar Biosciences to Host Conference Call with Texas Oncology Hematologist M. Yair Levy, M.D. on January 19, 2024 to Discuss Iopofosine I 131 Pivotal Topline Results

MariaDB Reaches Agreement to Amend Senior Secured Promissory Note
MRDB

Business Wire

6 months ago

MariaDB Reaches Agreement to Amend Senior Secured Promissory Note

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting
MRDB

GlobeNewswire

6 months ago

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024
MRDB

Business Wire

7 months ago

Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024

New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
MRDB

GlobeNewswire

7 months ago

New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis
MRDB

Newsfile

7 months ago

Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

Gold CEO Firing Deals Fresh Blow to Mining’s Battered Reputation
MRDB

Bloomberg

7 months ago

Gold CEO Firing Deals Fresh Blow to Mining’s Battered Reputation

Comstock Inc. Publishes its 4Q23 Stakeholder Perception Analysis Report
MRDB

GlobeNewswire

7 months ago

Comstock Inc. Publishes its 4Q23 Stakeholder Perception Analysis Report

Kingstone Completes Quota Share Placement
MRDB

ACCESSWIRE

7 months ago

Kingstone Completes Quota Share Placement

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
MRDB

GlobeNewswire

7 months ago

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MRDB

GlobeNewswire

7 months ago

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MRDB

Business Wire

7 months ago

MariaDB Files Form 10-K Annual Report

KULR Selected by One of the World’s Largest Private Space Exploration Companies for Enhanced Battery Safety Solutions
MRDB

GlobeNewswire

7 months ago

KULR Selected by One of the World’s Largest Private Space Exploration Companies for Enhanced Battery Safety Solutions

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
MRDB

GlobeNewswire

7 months ago

Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

MultiMetaVerse Announces Release of Restricted Closing Payment Shares
MRDB

PR Newswire

7 months ago

MultiMetaVerse Announces Release of Restricted Closing Payment Shares

Beyond Air Independent Director Acquires 102% More Stock
MRDB

Simply Wall St.

7 months ago

Beyond Air Independent Director Acquires 102% More Stock

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc
MRDB

GuruFocus.com

7 months ago

Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc

Workhorse Group Expands West Coast Presence, Adding The Truck Shop as its Latest Dealer
MRDB

GlobeNewswire

7 months ago

Workhorse Group Expands West Coast Presence, Adding The Truck Shop as its Latest Dealer

MRDB

GlobeNewswire

7 months ago

Huize Partners with PICC Life Insurance to Launch “Darwin Critical Care No.8 – Advanced” – A Customized Critical Illness Insurance Product

MariaDB Finalizes Spinoff of SkySQL
MRDB

Business Wire

7 months ago

MariaDB Finalizes Spinoff of SkySQL

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
MRDB

GlobeNewswire

8 months ago

Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases
MRDB

Business Wire

8 months ago

Precision BioSciences Announces Publication in Nature Metabolism Supporting ARCUS® In Vivo Gene Editing as a Potentially Curative Treatment for Mitochondrial Diseases

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
MRDB

GlobeNewswire

8 months ago

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

Global Self Storage Declares Fourth Quarter 2023 Dividend
MRDB

ACCESSWIRE

8 months ago

Global Self Storage Declares Fourth Quarter 2023 Dividend

Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
MRDB

GlobeNewswire

8 months ago

Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role

Snail Games Unleashes ARK: Survival Ascended on PlayStation®5 - Cross-Platform Gameplay and 250+ Mods Await
MRDB

GlobeNewswire

8 months ago

Snail Games Unleashes ARK: Survival Ascended on PlayStation®5 - Cross-Platform Gameplay and 250+ Mods Await

Insider Buying: CTO Joseph Wong Acquires 90,000 Shares of Advanced Emissions Solutions Inc
MRDB

GuruFocus.com

8 months ago

Insider Buying: CTO Joseph Wong Acquires 90,000 Shares of Advanced Emissions Solutions Inc

CompoSecure Designated a Microsoft-Compatible FIDO2 Security Key Vendor for Passwordless Authentication
MRDB

GlobeNewswire

8 months ago

CompoSecure Designated a Microsoft-Compatible FIDO2 Security Key Vendor for Passwordless Authentication

Huize Holding Limited (NASDAQ:HUIZ) Q3 2023 Earnings Call Transcript
MRDB

Insider Monkey

8 months ago

Huize Holding Limited (NASDAQ:HUIZ) Q3 2023 Earnings Call Transcript

Is Advanced Emissions Solutions (ADES) Outperforming Other Industrial Products Stocks This Year?
MRDB

Zacks

8 months ago

Is Advanced Emissions Solutions (ADES) Outperforming Other Industrial Products Stocks This Year?

There's A Lot To Like About Village Bank and Trust Financial's (NASDAQ:VBFC) Upcoming US$0.18 Dividend
MRDB

Simply Wall St.

8 months ago

There's A Lot To Like About Village Bank and Trust Financial's (NASDAQ:VBFC) Upcoming US$0.18 Dividend

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
MRDB

GlobeNewswire

8 months ago

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

13 Cheap Energy Stocks To Buy
MRDB

Insider Monkey

8 months ago

13 Cheap Energy Stocks To Buy

MRDB

Associated Press Finance

9 months ago

VTv Therapeutics: Q3 Earnings Snapshot

MRDB

Associated Press Finance

9 months ago

Regulus: Q3 Earnings Snapshot

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
MRDB

GlobeNewswire

9 months ago

vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates
MRDB

PR Newswire

9 months ago

Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates

Astra Announces Closing of Additional Debt Financing and Waiver of Previously Announced Defaults
MRDB

Business Wire

9 months ago

Astra Announces Closing of Additional Debt Financing and Waiver of Previously Announced Defaults

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data
MRDB

GlobeNewswire

9 months ago

Aligos Therapeutics to Host KOL Event to Discuss ALG-000184 Phase 1, AASLD Late Breaker Data

STRT vs. MBLY: Which Stock Is the Better Value Option?
MRDB

Zacks

9 months ago

STRT vs. MBLY: Which Stock Is the Better Value Option?

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
MRDB

PR Newswire

9 months ago

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Share on Social Networks: